GLOBAL CLINICAL EVIDENCE
NICE, the National Institute for Health and Care Excellence has accredited the process used by Truven Health Analytics to develop content used in its Micromedex Solutions.
View the press release here
At Truven Health we understand how drug approvals, care guidelines and clinical practices are unique to each country. At the same time, we understand that the patient is at the core of everything you do; that evidence-based medicine and best practices form the cornerstone of protecting patient safety.
More than 5,500 hospitals and healthcare institutions in 83 countries rely on the global clinical evidence of Truven Health Micromedex Solutions. For almost 40 years, our customers have trusted the medication management, disease and condition therapy, and toxicology information of Micromedex to support them in making critical patient care decisions.
We provide global evidence to support local patient care decisions. Micromedex contains detailed evidence around off-label drugs as well as the approved medicines of Canada, Italy, the UK and USA. And our global solutions continue to grow. The Micromedex Clinical Knowledge interface can be viewed in nine languages. Our patient education materials are available in 15 languages, including Arabic, English, Japanese and Spanish.
Our solutions support medication management, disease and condition therapy, toxicology control and patient education as well as real-time clinical surveillance and analytics. You can access these solutions anytime, anywhere: online, on tablets and on smart phones.
Micromedex Solutions help hospitals achieve regulatory compliance, and Joint Commission International as well as other national and international accreditation. When integrated into your hospital’s systems, our solutions provide an electronic audit trail to document patient care to save you time, and help you comply with regulatory guidelines.
Download our convenient mobile apps.
Solutions from Truven Health Analytics are being rebranded as IBM Watson Health